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Summary Laminin promotes the malignant phenotype, and the expression of certain laminin receptors is increased in malignancy.
Previously, we demonstrated that a laminin-adhesive subolone of a human colon cancer cell line showed increased tumorigenicity in nude
mice and increased affinity of the P, integrin for laminin relative to the laminin-non-adhesive subolone. The total amount of either 1 integrin
protein or mRNA did not increase. As levels of the 32/67-kDa laminin receptor (67LR) correlate with malignancy, we examined 67LR
expression in the laminin adhesion-selected human colon cancer cells. The laminin-adhesive subolone, which was more tumorigenic in both
heterotopic and orthotopic locations than in a laminin-non-adhesive subolone, showed cell-surface membrane staining of 67LR, whereas the
laminin-non-adhesive subolone showed cytoplasmic staining of 67LR. No difference in either the amount of 67LR mRNA or the amount of
protein was observed in the parental cells than in the laminin-adhesive and non-adhesive subolones. When assayed on a laminin affinity
column, more 67LR molecules bound to the column with cell extracts from the laminin-adhesive subolone than was observed with the non-
adhesive subclone. These findings suggest that the increased tumorigenicity of laminin adhesion-selected tumour cells might be due to an
alteration in the distribution and/or adhesiveness of multiple receptors including 67LR and P1 integrin.
Keywords: laminin; 32/67-kDa laminin receptor; laminin adhesion selection; colon cancer cell line; immunohistochemistry; affinity
chromatography
Laminin, a major component of basement membrane, exhibits
diverse biological activities in both normal cells and tumour cells
(Kleinman et al, 1993). Co-injection of laminin and tumour cells
increased tumorigenicity as well as metastasis (Terranova et al,
1984), whereas certain fragments decrease tumorigenicity.
Adhesion of cancer cells to laminin is mediated through various
cell-surface receptors, which may serve different functions.
Among the known surface-binding proteins, the 32/67-kDa
laminin receptor (67LR) was the first protein identified as a high-
affinity receptor (Malinoff and Wicha, 1983). The expression of
this 67LR is increased in several human cancers: 67LR is higher in
colon cancer tissue than in adjacent normal tissue, both at the
protein level and at the mRNA level (Horan-Hand et al, 1985;
Cioce et al, 1991). The expression ofthis receptor correlates posi-
tively with tumour progression or Dukes' stage of colon cancer
(Mafune et al, 1990). Themolecular weight ofthis receptoris vari-
able when examined with immunoreactive antibody by Western
blot and molecular weights of 32, 38, 45, 54 and 67 kDa are
observed. In contrast, only one mRNA at 1.1 kb has been detected.
The reason for the different sizes is probably post-translational
modifications but that has not yet been described.
Aznavoorian et al (1990) selected colon cancer cell lines
according to their invasiveness through amnion. The isolated,
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highly invasive human colon cancer cell line migrated more
strongly towards laminin in vitro and showed strong laminin-
binding activity. Similarly, Yamamura et al (1993) selected malig-
nant melanoma cells based on their adhesiveness to the YIGSR
peptide, one of the biologically active sites of laminin. YIGSR-
adherent melanoma cells were more malignant in nude mice than
YIGSR-non-adherent cells. The molecular mechanisms under-
lying the biological difference have not been defined in the above
two selected cell lines.
We selected a colon cancer cell line based on its adhesiveness to
laminin (Jun et al, 1994). We have characterized the adherent and
non-adherent cells in terms oftheirbiological tumorigenic activity
andR, integrin expression (Kim et al, 1995). The laminin-adhesive
subclone was more tumorigenic and invasive, and showed
membranous distribution of ,B integrin. The J3, integrin of the
laminin-adhesive subclone had higher affinity to laminin than that
ofthe laminin-non-adhesive subclone.
In this paper, the laminin adhesion-selected colon cancer cells
were analysed for expression of 67LR. The results showed that
differences in tumorigenicity might be caused by alterations in
multiple laminin receptors, includingR1 integrin and 67LR.
MATERIALS AND METHODS
Cell culture and selection
Laminin and Matrigel were prepared from the Engelbreth-
Holm-Swarm (EHS) tumour, which is known to produce a large
amount of basement membrane. The preparation methods have
been described elsewhere (Kleinman et al, 1986; Martin and
Timpl, 1987). Antibodies to the 67LR were prepared against
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either a synthetic peptide from the deduced sequence of amino
terminus (HK-149) or a fusion protein from the carboxy terminus
(HK-48) (Clement et al, 1990). Antibody against 110 kDa laminin
receptor was prepared using purified protein from fetal mouse
brain (Kleinman et al, 1991).
The establishment of ET human colon cancer cell line (also
named LCC-C1) and selection of subclones has been described
previously (Jun et al, 1994). In brief, a biopsy specimen from a
colon adenocarcinoma (Dukes' stage B2) was minced, mixed with
0.5 ml of Matrigel (14 mg ml-') and injected subcutaneously into
a nude mouse. The resulting tumour was harvested and again
injected into another nude mouse after mincing and mixing with
Matrigel. The tumour from the third xenograft was enzymatically
digested with trypsin-EDTA (0.05% trypsin in 0.53 mM EDTA) to
yield a single-cell suspension. These cells were cultured in
RPMI-1640 growth medium (Gibco-BRL) containing 10% fetal
calf serum (Hyclone), insulin (5 jg ml-'), transferrin (5 ,ug ml-1),
selenium (5 ug ml-') penicillin (100 g ml-'), streptomycin
(100 jig ml-') and gentamicin (50 jig ml-').
The selection procedure was as follows. The cells were detached
from the plastic dish and dispersed with trypsin-EDTA; after
washing to remove the trypsin-EDTA, the cells were plated onto a
Nunc culture plate (150 mm diameter) which hadbeen coated with
0.7 mg ml-' laminin solution for 1 h at 37°C. After a 1-h incuba-
tion on the laminin-coated plates, unattached cells were collected,
cultured until they became confluent and harvested again. The
selection procedures were repeated 26 times to yield the ET- cells.
Similarly, the attached cells on the laminin-coated culture plates
were repeatedly selected 35 times to yield ET+ cells.
Heterotransplantation
Parental ET cells, ET+ cells or ET- cells were injected into the
caecal wall of nude mice, with six mice used for each cell type.
The cells at 70% confluency were enzymatically dispersed into
single cells. Fifty thousand cells were suspended in 0.2 ml of
Matrigel at 4°C. The mice were anaesthetized and the
Matrigel-cell mixtures were injected into the wall of the caecum.
The mice were sacrificed 30 days later and the histology of the
caecal tumours was examined after haematoxylin-eosin staining.
Attachment assay
Cell attachment was assessed in round-bottom 96-well culture
plates. The plates were coated with varying amounts oflaminin in
50 jl ofMilli-Q water (Kim et al, 1994). After drying the laminin,
the wells were blocked by the addition of 0.2 ml of 3% bovine
serum albumin (BSA) in RPMI-1640 medium for 1 h and then
washed with the 0.1% BSA solution. The cells, detached by
trypsin-EDTA, were resuspended in 0.1% BSA in RPMI-1640
medium, added to the wells (40 000 cells in 0.2 ml) and incubated
in a carbon dioxide incubator for 1 h. After incubation, the
unattached cells were removed by inverting the plates and gentle
tapping, and the attached cells were stained with 0.2% crystal
violet solution in 20% methanol for 10 min. The optical density at
560 nm was measured after dissolving the stained cells with a 1%
sodium dodecyl sulphate (SDS) solution.
Western blot
Near-confluent cells were dissolved in 50 mm Tris-HCl buffer
containing 150 mm sodiumchloride, 1% Triton-X 100, 0.1% deoxy-
cholic acid, 0.1% SDS and 2 mM phenylmethylsulphonyl fluoride
(PMSF). Protein content was measured by the BCA method, and
50 jig oftotal cell lysate protein was separated on 7.5% SDS-poly-
crylamide gels under reducing conditions with 0.1 M DTT. The
proteins were electroblotted to polyvinylidene difluoride paper and
the blot was immersed in 50 mM Tris-HCl (pH 7.4) containing
150 mm sodium chloride, 0.1% Tween-20 and 5% non-fat dry milk
for 1 h. The primary antibodies against 67LR (HK-149 or HK-48)
(Clement et al, 1990) were diluted to 1:5000 and incubated for 2 h.
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Figure 1 Attachment of subclones to laminin-coated plates. The 96-well
plates were coated with various amounts of laminin and attached cells were
compared after staining with crystal violet
Figure 2 Western blot of 67LR with HK-149 antibody. Cell Iysates were
electrophoresed on a 7.5% SDS gel, transferred to a nitrocellulose
membrane and reacted with the HK-149 antibody. The three cell lines
showed similar intensity of immunoreactivity, including the major 45-kDa
band
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Figure 3 Northern blot of mRNA from colon cancer cell lines with cDNA for
67LR. There was no difference of the amount of transcript between the three
lanes
Biotinylated anti-rabbit IgG and avidine-biotin-peroxidase
complex were subsequently added, and ECL (Amersham) was used
to detect the immune complexes by chemiluminescence.
Northern blot
Total RNA was extracted from near confluent cells. The cells were
scraped into a solution of guanidine thiocyanate and RNA was
purified by ultracentrifugation on a caesium chloride cushion. An
aliquot (10 ,ug) of total RNA was run on a 1% agarose-formalde-
hyde gel and transferred to a nytran filter. A full length 32/67-kDa
cDNA (Segui-Real et al, 1989), cloned from a human placental
library, was obtained from Dr Y Yamada (NIH, MD, USA). The
insert of 1.1 kb was [32P]dCTP by random oligonucleotide primer
extension. After hybridization and stringent washing, the filter was
autoradiographed. Each blot was repeated twice with a different
preparation ofRNA.
Immunohistochemistry
The cells were cultured on 13 mm round Thermanox cover slips
(Nunc, Naperville, IL, USA) for 3 days and fixed with 4%
formaldehyde. After washing, the cells were blocked with non-
immune serum, then incubated with 67LR antibodies (either HK-
48 or HK-149 at 1:800), followed by incubation with biotinylated
anti-rabbit IgG. Afterwashing, bound antibody was detected using
an ABC immunostaining kit (Vector, Burlingame, CA, USA) and
diaminobenzidine-hydrogen peroxide.
Laminin affinity chromatography
Near-confluent colon cancer cells were homogenized in 100 mM
Tris-HCl (pH 7.4) buffer containing 25 mM n-octyl-4-D-glucopyra-
noside, 150 mm sodium chloride, 2 mM PMSF, 1 mm manganese
chloride and centrifuged at 10 OOOg for 15 min. The supernatant
was incubated overnight at4°C with laminin-Sepharose beads. The
beads were then packed in a column and washed with the same
buffer until protein elution stopped. The bound fractions were
eluted with the same buffer containing 20 mM EDTA instead of
Figure 4 (A) Immunohistochemical staining of parenatal cell line with 67LR
antibody. (B) Staining the ET(+) cells with the same antibody exhibited
membraneous distrubution of 67LR. (C) ET(-) cells expressed the 67LR in
the cytoplasm
manganese chloride. The eluates were dialysed, lyophilized and
separatedusing 7.5% SDS-PAGE underreducing conditions. After
electroblotting, western blot staining was performed with the HK-
149 ,antibody. In addition, western blot with antibody against the
1O-kDa laminin receptor (Kleinman et al, 1991) was performed.
RESULTS
The attachment of-the laminin-adherent, laminin-non-adherent and
parental subclones was compared (Figure 1). The ET+ subclone
showed the strongest attachment to laminin at concentrations
higherthan 1 jg perwell in the 96-well plate. ET-cells showed the
least attachment among the three cells, although the difference
between parental and ET- was not significant at concentrations
higher than 1 jig per well.
In vitro morphology ofET+ cells showed flattening of the cyto-
plasm around cell aggregates and formation of a central volcano-
like structure as previously reported (Jun et al, 1994). The
cell-to-cell border was conspicuous in the ET+ cells. The ET- cells
showed dome-shaped cell aggregates without flattening at the
periphery and the volcano-like structure was not observed. The
parental cells showeddome-shaped aggregates with inconspicuous
cell borders.
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Figure 5 Western blot for the 67LR following laminin affinity
chromatography. (A) The laminin-binding fractions were separated by SDS-
PAGE followed by electroblotting and immunostaining with 67LR antibody.
Several bands (arrows) including 67, 45 and 32 kDa are observed. (B) The
same blot was stripped and immunostained with 110 kDa laminin receptor
antibody. A similar level of expression was noted (arrowhead) between the
two subclones
We compared the tumorigenicity of these tumour cells in the
caecum of the nude mice. Orthotopic injection of tumour cells
represents the best approach for measuring the invasiveness or
metastatic potential oftumour cells (Togo et al, 1995). ET+ tumour
cells produced large caecal masses in all six mice, whereas
parental cells developed tumours in three out of six mice and ET-
cells produced tumours in two out ofsix mice. The tumour volume
for the ET+ cells was much greater (112.4 ± 40.9 mm3) than that
of either the parental cells (7.3 ± 4.2 mm3) or the ET- cells
(3.6 ± 1.9 mm3). Histologically, the ET+ cell-derived tumours were
less differentiated and formed smaller glands with minute lumina.
Tumours from ET- or parental cells were well-differentiated
adenocarcinomas. The outer and inner diameter of the individual
gland were larger than those of ET+ tumours, and nuclei were
elongated and slender. Tumours from ET+ cells were moderately
differentiated adenocarcinomas and the nuclei were ovoid. None
of the caecally grown tumours metastasized to the liver or to
other organs.
Western blot analysis of total cellular 67LR was performed on
lysates from cultured cells using two antibodies against 67LR. One
of these (HK-149) was raised against a 17-mer synthetic peptide
from the N-terminal region of 67LR and the other (HK-48) was
raised against a bacterial fusion protein coded for the ,3-galactosi-
dase gene plus 0.9-kb cDNA sequence from C-terminal region
(Clement et al, 1990). Using either antibody, the major protein
band migrated at 45 kDa. The mobility and amount of this protein
was not different in the three cell lines (Figure 2). Other cross-
reactive bands are observed but their amounts are low compared
with the 45-kDa band.
Northern blot analysis of cultured cells using 67LR cDNA
(Segui-Real et al, 1989) revealed a 1.1-kb transcript. There was no
difference in the amount of mRNA in the three cell lines (Figure
3). We conclude that the transcription and expression of 67LR
were not different among the three cell lines.
Immunohistochemical localization of67LR was performed with
the HK-149 antibody. In ET+ cells, the antigen was distributed
along the cell membrane and in the central lumen-like structure in
a linear pattern (Figure 4B). In contrast, ET- cells did not show a
membrane-staining pattern. The 67LR was localized in the cyto-
plasm of ET- cells in a spotty distribution (Figure 4C). Parental
cells showed diffuse staining both in the membrane and cytoplasm
(Figure 4A). The staining pattern was similar, when HK-48 anti-
body was used instead ofHK-149 (data not shown).
Laminin affinity chromatography of cell lysates using a
laminin-Sepharose affinity column was carried out. The EDTA-
eluted fraction, separated on 7.5% SDS-PAGE under reducing
conditions, revealed that the 45-kDa 67LR is more abundant in
ET+ cells than in ET- cells (Figure 5). Lesser amounts of other
species that react with antibody are observed and may either be
breakdown products (the lower bands) or related species (upper
bands) as observed previously (Clement et al, 1990; Kleinman et
al, 1991). The same fractions reacted with an antibody to another
laminin receptor of 110kDa. The level of 110-kDa laminin
receptor did not differ between the two subclones. These findings
suggested that the 67LR is able to bind laminin better on the ET+
cells than on ET- cells, although the total amounts of 67LR were
similar in the two cell lines. Assuming that the binding affinity is
higher in the membranous fraction than the cytoplasmic fraction,
the above findings corresponds with the different cellular localiza-
tion ofthose cell lines. Other explanations are also possible.
DISCUSSION
We have examined the expression of the 67LR from subclones of
colon cancer cell lines that originated from a single patient. Cells
from the parental cell line were selected for laminin adhesiveness.
We found that laminin-adherent cells had greater tumorigenic
ability in orthotopic as well as in heterotopic sites than the non-
adherent or parental cells. We also found that the laminin adhe-
sion-selected subclone did not differ in transcription or protein
expression of 67LR, whereas the cellular distribution was
markedly different. This finding is similar to the differential
expression of P integrin in these subclones, which we demon-
strated previously (Kim et al, 1995). We are not sure why both of
these adhesion receptors are not fully expressed on the cell
surface. A possible defect in protein transport may be involved.
It is not certain why we detect mainly 45-kDa protein in the
colon cancer cells. As shown in the Northern blot, the mRNA is
1.1 kb and the deduced amino acid sequence codes for a 32-kDa
protein. It is unlikely that the 32-kDa protein forms a dimer to
become 67 kDa because reducing agents do not change its molec-
ular weight. It has been proposed that the 67-kDa molecule is a
chimeric molecule resulting from post-transcriptional association
between the 37-kDa laminin receptor precursor protein (derived
from mRNA of32-kDa amino acid sequence) and a 3-galactoside-
binding lectin (Castronovo, 1993). Thus, the molecular weight of
this protein might vary according to the modification in a cell
type-specific manner. Variable-sized proteins (37, 45 or 67 kDa)
have been identified with these antibodies (Clement et al, 1990;
Weeks etal, 1991).
There is still controversy as to whether 67LR is a surface
membrane receptor. Although several researchers have demon-
strated that 67LR is a membrane-associated protein that interacts
with the cytoskeleton (Cody and Wicha, 1986), Weweret al (1986)
raised the question because the full-length cDNA encoded a much
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smaller protein (32 kDa) that lacked a membrane-spanning
domain. Our data show that 67LR can be expressed either on the
cell membrane or in the cytoplasm, and suggested that the expres-
sion pattern might be related to malignancy.
The YIGSR peptide, derived from the laminin 1P chain, inhibits
tumour growth and metastasis (Iwamoto et al, 1987). This peptide
competitively binds to the 67LR (Graf et al, 1987), and it was
subsequently demonstrated that YIGSR induced spreading and
stress fibre formation through 67LR. The 67LR was co-localized
with a-actinin and vinculin, which are structural proteins of the
cells (Massia et al, 1993). The above findings suggested that the
YIGSR is a ligand site of67LR and that the YIGSR mediated anti-
metastatic effect might be due to the competitive blocking the
67LR by soluble peptides.
A strong correlation has been observed between 67LR and
human colon carcinomas. Horan-Hand et al (1985) first described
an elevated expression of 67LR in colorectal carcinoma compared
with normal colonic mucosa or colonic adenoma. Yow et al (1988)
isolated the 67LR by differential hybridization using colon cancer
cells and normal tissue. The investigation of surgically resected
samples and metastatic lesions by Mafune et al (1990) confirmed
the increased abundance of67LR in colon carcinoma, postulating a
role of this receptor as a marker of human colorectal cancer
progression and aggressiveness. The observation of a higher level
of laminin receptor expression on metastatic colon cancer than in
the primary tumour (Cioce et al, 1991), strongly suggests that an
increased level of laminin receptor expression is associated with a
more invasive phenotype and a higher metastatic potential. A posi-
tive association of 67LR expression and tumour progression in
human gastric carcinoma was also recently demonstrated (Lee et al,
1996). We tried growing these cells orthotopically to see if these
cells could metastasize, but no metastatic lesion was observed. This
may not be unexpected as the level of67LR did not change.
Several studies have shown that not only in gastrointestinal
cancer but also in human breast cancer, there is increased expres-
sion of67LR, and the level ofthis receptor appeared to be related
to increased invasiveness and metastatic potential (Martignone et
al, 1993). Furthermore, oestrogen, which is known to modulate the
progression of breast cancer, enhanced the expression of 67LR at
both the protein and mRNA level in oestrogen receptor-positive
human breast cancercells (Castronovo et al, 1989). These observa-
tions are consistent with the fact that oestrogen receptor-positive
breast carcinomas are clinically more aggressive than oestrogen
receptor-negative carcinomas. Oestrogen-induced exacerbation of
oestrogen receptor-positive breast cancer could also be related to
the up-regulation of67LR.
In summary, this study revealed that subcloned colon cancer
cells of varying malignant potential exhibited a different expres-
sion pattern of67LR. Based on our previous work with these cells
(Kim et al, 1995), we find that the adhesion selection altered
the distribution of at least two potential laminin receptors,
including I3 integrin and 67LR. These alterations could be respon-
sible for the difference in laminin adhesiveness, invasiveness and
tumorigenicity.
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